SummaryA 2025 JAMA study found many older Americans stop GLP-1 weight loss drugs within a year. High costs, insurance loss, strong side effects, muscle loss, and limited personalized medical monitoring drive discontinuation, despite risks of weight regain and worsening metabolic health after stopping treatment. Read on to know more about the reasons.